Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X

Anadolu Kardiyoloji Dergisi

Volumn 9, Issue 5, 2009, Pages 371-379

  Şen, Nihat ^a   Tavil, Yusuf ^a   Erdamar, Hüsamettin ^b   Yazici, Hüseyin Uǧur ^a   Çakir, Erdinç ^c   Akgül, Emin Özgür ^c   Bilgi, Cumhur ^c   Erbil, Mehmet Kemal ^c   Poyraz, Fatih ^a   Okyay, Kaan ^a   Turfan, Murat ^a   Cemri, Mustafa ^a  

^a GAZI UNIVERSITY   (Turkey)

^b BEYTEPE MILITARY HOSPITAL   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Asymmetric dimethylarginine; Cardiac syndrome X; Endothelial function; Nebivolol; Nitric oxide

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METOPROLOL; N(G),N(G) DIMETHYLARGININE; NEBIVOLOL;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ST SEGMENT DEPRESSION; SYNDROME X; TREADMILL EXERCISE;

ADRENERGIC BETA-ANTAGONISTS; ARGININE; BENZOPYRANS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; EXERCISE TEST; HEART CATHETERIZATION; HEART RATE; HUMANS; METOPROLOL; MICROVASCULAR ANGINA; NITRIC OXIDE; SINGLE-BLIND METHOD;

EID: 70849100872     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kemp HG. Left ventricular function in patients with anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32: 375-376
2. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez- Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-1660
3. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-1664 (Pubitemid 23157347)
4. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037
5. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. Long-term angiotensinconverting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002; 90: 974-982
6. Fragasso G, Chierchia SL, Pizzetti G, Rossetti E, Carlino M, Gerosa S, et al. Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade. Heart 1997; 77: 32-39
7. Van de Water A, Janssens W, Van Neuten J, Xhonneux R, De Cree J, Verhaegen H, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta-1-adrenergic antagonist. J Cardiovasc Pharmacol 1988; 11: 552-563 (Pubitemid 18128104)
8. Van Neuten L, Taylor FR, Robertson JL. Nebivolol versus atenolol and placebo in essential hypertension: a double-blind randomized trial. J Hum Hypertens 1998; 12: 135-140 (Pubitemid 28062129)
9. Ignarro LJ, Byrns RE, Trinh K, Sisodia M, Buga GM. Nebivolol: a selective beta (1)adrenergic receptor antagonist relaxes vascular smooth muscle by nitric oxide- and cyclic GMP dependent mechanisms. Nitric Oxide 2002; 7: 75-82.
10. Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L et al. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine / NO dependent mechanism. J Pharmacol Exp Ther 1995; 274: 1067-1071
11. Dawes M, Brett SE, Chowiencyk PJ, Mant TG, Ritter JM. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension. Br J Clin Pharmacol 1999; 48: 460-463 (Pubitemid 29417735)
12. Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol 2002; 18: 371-379 (Pubitemid 34752374)
13. Miranda, KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71. (Pubitemid 34146173)
14. Chen BM, Xia LW, Zhao RQ. Determination of N(G),N(G)- dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997; 692: 467-471 (Pubitemid 27217852)
15. Kolasinska-Kloch W, Lesniak W, Kiec-Wilk B, Malczewska-Malec M. Biochemical parameters of endothelial dysfunction in cardiological syndrome X. Scand J Clin Lab Invest 2002; 62: 7-13.
16. Kayikçioǧlu M, Payzin S, Yavuzgil O, Kültürsay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X. Eur Heart J 2003; 24: 1999-2005.
17. Palloshi A, Fragasso G, Piatti P, Monti LD, Setola E, Valsecchi G, et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 2004; 93: 933-935
18. Gao Y, Nagao T, Bond RA, Janssens WJ, Vanhoutte P. Nebivolol induces endothelium-dependent relaxation of canine coronary arteries. J Cardiovasc Pharmacol 1991; 17: 964-969
19. Bowman AJ, Chen CPL, Ford GA. Nitric oxide mediated venodilator effects of nebivolol. Br J Clin Pharmacol 1994; 38: 199-204.
20. Van de Water A, Xhonneux R, Reneman RS, Janssen PA. Cardiovascular effects of nebivolol and its enantiomers-a comparison with those of atenolol. Eur J Pharmacol 1988; 156: 95-103. (Pubitemid 18257842)
21. Ritter JM. Nebivolol: endothelium-mediated vasodilating effect. J Cardiovasc Pharmacol 2001; 38 Suppl 3: S13-6.
22. Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, et al. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta 1-selective receptor blockade. J Hypertens 2002; 20: 421-428 (Pubitemid 34913741)
23. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002; 62: 265-284 (Pubitemid 34169434)
24. Tzemos N, Lim PO, McDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 2001; 104: 511-514 (Pubitemid 32738117)
25. Oǧuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fiçi F. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus. Anadolu Kardiyol Derg 2007; 7: 383-387 (Pubitemid 350303384)
26. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999; 43: 542-548 (Pubitemid 29369253)
27. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99: 1141-1146 (Pubitemid 29120084)
28. Surdacki A, Nowichi M, Sandmann J, Tsikas D, Böger RH, Bode- Böger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999; 33: 652-658 (Pubitemid 29164831)
29. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, et al. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 2001; 88: 1201-1203 (Pubitemid 33043860)
30. Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287: 1420-1426 (Pubitemid 34250505)
31. Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006; 48: 956-963 (Pubitemid 44292455)
32. Yavas N. The assessment of affects of the nebivolol treatment with exercise stress test on cardiac syndrome X patients with stage 1 hypertension. Izmir Atatürk Training and Research Hospital, Izmir. 2006.
33. Lu TM, Ding YA, Leu HS, Yin WH, Sheu WHS, Chu KM. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol 2004; 94: 157-161 (Pubitemid 38902861)
34. Walker HA, McGing E, Fisher I, Böger RH, Bode-Böger SM, Jackson G, et al. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol 2001; 38: 499-505.